Status
Lab Tested
Tirzepatide
Select Size
₱2,000
In Stock
A dual GIP/GLP-1 receptor agonist peptide studied in metabolic and weight-management research.
Key Benefits
- Dual receptor agonist (GIP + GLP-1)
- Studied for body-weight reduction in trials
- Researched for appetite regulation
- Investigated for insulin sensitivity
- Examined for visceral-fat models
About This Peptide
Detailed information about Tirzepatide.
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied in clinical research for its effects on body weight, appetite, and insulin sensitivity.
Tirzepatide is supplied as a lyophilised powder vial and is lab tested to verify identity and purity. Every batch comes with a Certificate of Analysis (COA) so you can verify exactly what you're receiving. This product falls under the Weight Management category.
For laboratory and research use only. Not for human or veterinary consumption. These products are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the U.S. FDA or the Philippine FDA.
